Latest Decortication Stories

LOS ANGELES, May 16, 2012 /PRNewswire/ -- At the 2nd Annual Symposium for Lung-Sparing Therapies for Malignant Pleural Mesothelioma held this weekend at the Sheraton Delfina in Santa Monica, CA, international experts again re-affirmed the general consensus that radical operations which remove a patient's lung, such as extrapleural pneumonectomy, do not have a place in the treatment of malignant pleural mesothelioma and may, in fact, do harm. Dr. Robert Cameron, Director of the UCLA...

MPM caused by exposure to asbestos; latest in IASLC's Journal of Thoracic Oncology Patients with early stage malignant pleural mesothelioma (MPM), a cancer that develops in the lining of the lungs, may be eligible for aggressive multi-modality therapy involving surgery, radiotherapy and chemotherapy. There are two main approaches, and controversy has existed about which approach is superior. One is called extrapleural pnemonectomy (EPP), a very extensive surgery where surgeons remove the...

LOS ANGELES, Feb. 21, 2012 /PRNewswire/ -- Mesothelioma experts will gather on Saturday, May 12th 2012 at the Sheraton Delfina in Santa Monica, CA for the 2nd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma. Dr. Robert Cameron, Director of the UCLA Mesothelioma Comprehensive Research Program and Chief of Thoracic Surgery at the West Los Angeles VA Medical Center, will lead the symposium again this year. Dr. Cameron has been a leading...

LOS ANGELES, Sept. 6, 2011 /PRNewswire/ -- The Pacific Meso Center (PMC) is pleased to announce and recognize generous donations from the law offices of Roger G. Worthington PC in San Pedro, California and The Asbestos Legal Center in San Francisco, California. PMC is part of The Pacific Heart, Lung & Blood Institute (PHLBI), a 501(c)(3) non-profit medical research institute, and serves as PHLBI's comprehensive research and support center for malignant pleural mesothelioma (MPM), an...